sb 203580 has been researched along with Encephalitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castaño, A; García-Cuervo, L; Jiménez, S; Pintado, C; Revilla, E; Ruano, D; Vitorica, J; Vizuete, ML | 1 |
Desobry, K; Gay, D; Grammas, P; Luo, J; Martinez, J; Riley, J; Sanchez, A; Tripathy, D; Yin, X | 1 |
2 other study(ies) available for sb 203580 and Encephalitis
Article | Year |
---|---|
Regional difference in inflammatory response to LPS-injection in the brain: role of microglia cell density.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Cell Count; Cell Line, Transformed; Cytokines; Disease Models, Animal; Encephalitis; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Imidazoles; Interleukin-10; Isothiuronium; Lipopolysaccharides; Male; Mice; Microglia; Nitric Oxide Synthase Type II; Pyridines; Rats; RNA, Messenger; Tumor Necrosis Factor-alpha | 2011 |
p38 MAPK: a mediator of hypoxia-induced cerebrovascular inflammation.
Topics: Alzheimer Disease; Animals; Cell Hypoxia; Cells, Cultured; Cerebrovascular Disorders; Encephalitis; Humans; Imidazoles; Mice; Mice, Transgenic; Microvessels; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats | 2012 |